The Evolving Use of Phototherapy in Combination with Other Treatments for Chronic Plaque Psoriasis

Zanolli M. Phototherapy arsenal in the treatment of psoriasis. Dermatol Clin. 2004 Oct; 22(4): 397–406.

Dawe R.S. , Wainwright N.J. , Cameron H. Narrowband ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol. 1998 May; 138(5): 833–9.

Stern R.S. , Thibodeau L.A. , Kleinerman R.A. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med. 1979 April; 300(15): 809–13.

Stern R.S. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001 May; 44(5): 755–61.

Yamauchi P.S. , Rizk D. , Lowe N.J. Retinoid therapy for psoriasis. Dermatol Clin. 2004 Oct; 22(4): 467–76.

Saurat J.H. , Geiger J.M. , Amblard P. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica. 1988; 177(4): 218–24.

Ruzicka T. , Sommerburg C. , Braun-Falco O. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol. 1990 April; 126(4): 482–6.

Lebwohl M. , Drake L. , Menter A. Consensus conference: Acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol. 2001 Oct; 45(4): 544–53.

Weischer M. , Blum A. , Eberhard F. No evidence for increased skin cancer risk in psoriasis patients treated with broad-band or narrow-band UVB phototherapy: a first retrospective study. Acta Derm Venereol. 2004; 84(5): 370–4.

Nijsten T.E.C. , Stern R.S. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: A nested cohort study. J Am Acad Dermatol. 2003 Oct; 49(4): 644–50.

Lebwohl M. , Christophers E. , Langley R. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol. 2003 Jun; 139(6): 719–27.

Gordon K.B. , Papp K.A. , Hamilton T.K. Efalizumab for patients with moderate to severe chronic plaque psoriasis: a randomized controlled trial. JAMA. 2003 Dec; 290(23): 3073–80.

Enbrel® (etanercept) prescribing information. Immunex Corp., Thousand Oaks, Calif. (2004 Oct).

Ortonne J.P. , Khemis A. , Koo J.Y.M. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis. J Eur Acad Dermatol Venereol. 2005; In press.

Gordon K.B. , Krueger G.G. , van de Kerkof P.C.M. Efficacy and safety of multiple courses of alefacept in combination with other psoriasis therapies. Poster presented at 63rd Annual Meeting of the American Academy of Dermatology, Feb. 18–22, 2005, New Orleans, La.

Jacobe H. , Winterfield L. Alefacept in combination with narrowband ultraviolet B light therapy for the treatment of chronic plaque psoriasis. Poster presented at the 63rd Annual Meeting of the American Academy of Dermatology, Feb. 18–22, 2005, New Orleans, La.

Woodson J. , Kircik L. , Kricorian G. Combination therapy with PUVA and etanercept in the treatment of severe psoriasis. Poster presented at 63rd Annual Meeting of the American Academy of Dermatology, Feb. 18–22, 2005, New Orleans, La.

Iyer S. , Yamauchi P. , Lowe N.J. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy. Br J Dermatol. 2002 Jan; 146(1): 118–21.

Leonardi C.L. , Powers J.L. , Matheson R.T. Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003 Nov; 349(21): 2012–20.